The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Management stated, the raising guidance going forward, it is primarily being driven by what we're seeing in the Mechanical Thrombectomy and NanoKnife spaces. Stephen Trowbridge said, We expect both to ...

The medical technology company announced the retirement of CEO Jim Clemmer. This news creates uncertainty for AngioDynamics -- and investors dislike uncertainty. However, the company's business ...

There’s not a lot of earnings news today… but there is some… and it’s not good. Medical devices manufacturer AngioDynamics (Nasdaq: ANGO) reported breakeven profits for Q2 this morning, and beat on ...

AngioDynamics raised its full-year sales outlook after logging a higher top line in its fiscal second quarter, as the company scooped up market share from competitors. The medical-technology company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The executive has led the Latham ...

AngioDynamics ( (ANGO)) has provided an update. On January 6, 2026, AngioDynamics reported financial results for its fiscal second quarter ended November 30, 2025, highlighted by 8.8% year-on-year pro ...